Year: 2019
Type: conference-abstract
Abstract: ConclusionWe developed a prognostic risk classification for patients with oligorecurrent PC treated with PSMA-PET-guided RT.Internal validation showed good accuracy.Patients with PSA levels at PSMA-PET-Imaging ≥0.8 ng/ml and the presence of other metastases (than bone or lymph node lesions) were at highest risk for biochemical relapse.External validation of the proposed RPA classification is planned as a next step.
Source: Radiotherapy and Oncology
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,000
OpenAlex ID: W2945560108
